Please use this identifier to cite or link to this item:
Title: Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients.
Authors: Ong, Sean Wei Xiang
Fong, Siew-Wai
Young, Barnaby Edward
Chan, Yi-Hao
Lee, Bernett
Amrun, Siti Naqiah 
Chee, Rhonda Sin-Ling
Yeo, Nicholas Kim-Wah
Tambyah, Paul 
Pada, Surinder 
Tan, Seow Yen
Ding, Ying
Renia, Laurent 
Leo, Yee-Sin 
Ng, Lisa FP
Lye, David Chien 
Keywords: COVID-19
chronic fatigue
persistent symptoms
Issue Date: Jun-2021
Publisher: Oxford University Press (OUP)
Citation: Ong, Sean Wei Xiang, Fong, Siew-Wai, Young, Barnaby Edward, Chan, Yi-Hao, Lee, Bernett, Amrun, Siti Naqiah, Chee, Rhonda Sin-Ling, Yeo, Nicholas Kim-Wah, Tambyah, Paul, Pada, Surinder, Tan, Seow Yen, Ding, Ying, Renia, Laurent, Leo, Yee-Sin, Ng, Lisa FP, Lye, David Chien (2021-06). Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients.. Open Forum Infect Dis 8 (6) : ofab156-. ScholarBank@NUS Repository.
Abstract: Background: The complications and sequelae of coronavirus disease 2019 (COVID-19) and their effect on long-term health are unclear, and the trajectory of associated immune dysregulation is poorly understood. Methods: We conducted a prospective longitudinal multicenter cohort study at 4 public hospitals in Singapore. Patients with COVID-19 were monitored for a median of 6 months after recovery from acute infection. Clinical symptoms and radiologic data were collected, along with plasma samples for quantification of immune mediators. The relationship between clinical symptoms and immune cytokine profiles was investigated. Results: Two hundred eighty-eight participants were recruited, and follow-up data were available for 183, 175, and 120 participants at days 30, 90, and 180 postsymptom onset, respectively. Symptoms related to COVID-19 were present in 31 (16.9%), 13 (7.4%), and 14 (11.7%) at days 30, 90, and 180. In a multivariable model, age >65 years, non-Chinese ethnicity, and the severity of acute infection were associated with increased likelihood of persistent symptoms. Recovered COVID-19 patients had elevated levels of proinflammatory interleukin (IL)-17A, stem cell factor, IL-12p70, and IL-1β and pro-angiogenic macrophage inflammatory protein 1β, brain-derived neurotrophic factor, and vascular endothelial growth factor at day 180 compared with healthy controls. Higher levels of monocyte chemoattractant protein-1 and platelet-derived growth factor-BB were detected in patients with persistent symptoms, versus symptom-free patients. Conclusions: Approximately 10% of recovered patients had persistent symptoms 6 months after initial infection. Immune cytokine signatures of the recovered patients reflected ongoing chronic inflammation and angiogenesis. Patients with COVID-19 should be monitored closely for emerging long-term health consequences.
Source Title: Open Forum Infect Dis
ISSN: 23288957
DOI: 10.1093/ofid/ofab156
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Persistant Symptoms OFID.pdf615.98 kBAdobe PDF




checked on Jan 26, 2023

Page view(s)

checked on Jan 26, 2023


checked on Jan 26, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.